Christine N. Metz

ORCID: 0000-0002-1013-1691
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Macrophage Migration Inhibitory Factor
  • Nuclear Receptors and Signaling
  • Endometriosis Research and Treatment
  • Pregnancy and preeclampsia studies
  • Vagus Nerve Stimulation Research
  • Birth, Development, and Health
  • Nicotinic Acetylcholine Receptors Study
  • Cardiovascular Issues in Pregnancy
  • Reproductive System and Pregnancy
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Respiratory Support and Mechanisms
  • Preterm Birth and Chorioamnionitis
  • Apelin-related biomedical research
  • Pregnancy-related medical research
  • Diabetes and associated disorders
  • Magnesium in Health and Disease
  • Cell Adhesion Molecules Research
  • Receptor Mechanisms and Signaling
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Heart Rate Variability and Autonomic Control
  • Neuroendocrine regulation and behavior
  • Trypanosoma species research and implications
  • Protease and Inhibitor Mechanisms
  • Vascular Anomalies and Treatments
  • Chemotherapy-induced organ toxicity mitigation

Feinstein Institute for Medical Research
2016-2025

Northwell Health
2016-2025

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2017-2024

Universität Hamburg
2023-2024

University Medical Center Hamburg-Eppendorf
2023-2024

Icahn School of Medicine at Mount Sinai
2014-2022

North Shore University Hospital
2004-2021

Northeast Georgia Medical Center
2021

Coney Island Hospital
2021

General Hospital of Serres
2021

Macrophage migration inhibitory factor (MIF) accounts for one of the first cytokine activities to have been described, and it has emerged recently be an important regulator innate adaptive immunity. MIF is upstream activator monocytes/macrophages, centrally involved in pathogenesis septic shock, arthritis, other inflammatory conditions. The protein encoded by a unique but highly conserved gene, X-ray crystallography studies shown define new fold structural superfamily. Although recent work...

10.1084/jem.20030286 article EN The Journal of Experimental Medicine 2003-06-02

Abstract Fibrocytes are a distinct population of blood-borne cells that display unique cell surface phenotype (collagen I+/CD11b+/CD13+/CD34+/CD45RO+/MHC class II+/CD86+) and exhibit potent immunostimulatory activities. Circulating fibrocytes rapidly enter sites tissue injury, suggesting an important role for these in wound repair. However, the regulatory processes govern differentiation mechanisms underlie migration to currently not known. We report herein ex vivo cultured can differentiate...

10.4049/jimmunol.166.12.7556 article EN The Journal of Immunology 2001-06-15

Transforming growth factor-β (TGF-β) is a potent regulator of cellular differentiation, proliferation, migration, and protein expression. These properties have been exploited to create variety bioassays for detecting the mature factor. In this paper, we describe highly sensitive specific, nonradioactive quantitative bioassay TGF-β based on its ability induce plasminogen activator inhibitor-1 (PAI-1) Mink lung epithelial cells (MLEC) were stably transfected with an expression construct...

10.1006/abio.1994.1042 article EN cc-by-nc-nd Analytical Biochemistry 1994-02-01

The protein known as macrophage migration inhibitory factor (MIF) was one of the first cytokines to be discovered and described 30 years ago a T-cell-derived that inhibited random macrophages in vitro. A much broader role for MIF has emerged recently result studies have demonstrated it released from anterior pituitary gland vivo. also is been identified secreted monocytes/macrophages upon glucocorticoid stimulation. Once released, acts "override" or counter-regulate suppressive effects...

10.1073/pnas.93.15.7849 article EN Proceedings of the National Academy of Sciences 1996-07-23
Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain Quentin Philippot and 95 more Jérémy Manry Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Boubacar Coulibaly Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Robert L. Nussbaum Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk

Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found about 10% patients with critical COVID-19 pneumonia, but not subjects asymptomatic infections. We detect auto-Abs 100-fold lower, more physiological, (100 pg/mL, 1/10 dilutions plasma) 13.6% 3,595 COVID-19, including 21% 374 > 80 years, and 6.5% 522 severe COVID-19. These antibodies also detected 18% the 1,124 deceased (aged 20 days-99 years; mean: 70...

10.1126/sciimmunol.abl4340 article EN cc-by Science Immunology 2021-08-10

Endothelial cell activation plays a critical role in regulating leukocyte recruitment during inflammation and infection. Based on recent studies showing that acetylcholine other cholinergic mediators suppress the production of proinflammatory cytokines via α7 nicotinic receptor (α7 nAChR) expressed by macrophages our observations human microvascular endothelial cells express nAChR, we examined effect stimulation vitro vivo. Using Shwartzman reaction, observed nicotine (2 mg/kg) novel agent...

10.1084/jem.20040463 article EN The Journal of Experimental Medicine 2005-04-04

Macrophage migration inhibitory factor (MIF) is an important pro-inflammatory mediator with the unique ability to counter-regulate effects of glucocorticoids on immune cell activation. MIF released from cells in response glucocorticoids, certain stimuli, and mitogens acts regulate glucocorticoid action ensuing inflammatory response. To gain insight into molecular mechanism action, we have examined role proliferation intracellular signaling events well characterized, NIH/3T3 fibroblast line....

10.1074/jbc.274.25.18100 article EN cc-by Journal of Biological Chemistry 1999-06-01

Transforming growth factor-β (TGF-β) is secreted by many cell types as part of a large latent complex composed three subunits: TGF-β, the TGF-β propeptide, and binding protein (LTBP). To interact with its surface receptors, must be released from disrupting noncovalent interactions between mature propeptide. Previously, we identified LTBP-1 transglutaminase, cross-linking enzyme, reactants involved in formation TGF-β. In this study, demonstrate that are substrates for transglutaminase....

10.1083/jcb.136.5.1151 article EN The Journal of Cell Biology 1997-03-10
Jérémy Manry Paul Bastard Adrian Gervais Tom Le Voyer Jérémie Rosain and 95 more Quentin Philippot Eleftherios Michailidis Hans-Heinrich Hoffmann Shohei Eto Marina García-Prat Lucy Bizien Alba Parra-Martínez Rui Yang Liis Haljasmägi Mélanie Migaud Karita Särekannu Julia Maslovskaja Nicolas de Prost Yacine Tandjaoui-Lambiotte Charles‐Édouard Luyt Blanca Amador-Borrero Alexandre Gaudet Julien Poissy Pascal Morel Pascale Richard Fabrice Cognasse Jesús Troya Sophie Trouillet‐Assant Alexandre Bélot Kahina Saker Pierre Garçon Jacques G. Rivière Jean‐Christophe Lagier Stéphanie Gentile Lindsey B. Rosen Elana Shaw Tomohiro Morio Junko Tanaka David Dalmau Pierre‐Louis Tharaux D. Sène Alain Stépanian Bruno Mégarbane Vasiliki Triantafyllia Arnaud Fekkar James R. Heath José Luis Franco Juan‐Manuel Anaya Jordi Solé‐Violán Luisa Imberti Andrea Biondi Paolo Bonfanti Riccardo Castagnoli Ottavia M. Delmonte Yu Zhang Andrew L. Snow Steven M. Holland Catherine M. Biggs Marcela Moncada‐Vélez Andrés A. Arias Lazaro Lorenzo Soraya Boucherit Dany Anglicheau Anna M. Planas Filomeen Haerynck Sotiriјa Duvlis Tayfun Özçelık Sevgi Keleş Ahmed Aziz Bousfiha Jalila El Bakkouri Carolina Ramírez‐Santana Stéphane Paul Qiang Pan‐Hammarström Lennart Hammarström Annabelle Dupont Alina Kurolap Christine N. Metz Alessandro Aiuti Giorgio Casari Vito Lampasona Fabio Ciceri Lucila Akune Barreiros Elena Domínguez‐Garrido Mateus Vidigal Mayana Zatz Diederik van de Beek Sabina Sahanic Ivan Tancevski Yuriy Stepanovskyy Oksana Boyarchuk Yoko Nukui Miyuki Tsumura Loreto Vidaur Stuart G. Tangye Sonia Burrel Darragh Duffy Lluís Quintana‐Murci Adam Klocperk Nelli Y. Kann Anna Shcherbina

Significance There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It important to estimate their quantitative impact on mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence these risk death increase with higher in men. Using an unvaccinated sample 1,261 deceased patients 34,159 individuals from general population, we found against IFNs strongly increased...

10.1073/pnas.2200413119 article EN cc-by Proceedings of the National Academy of Sciences 2022-05-16

We recently described a novel population of blood-borne cells, termed fibrocytes, that display distinct cell surface phenotype (collagen+/CD13+/CD34+/CD45+), rapidly enter sites tissue injury, and contribute to scar formation. To further characterize the role these cells in vivo, we examined expression type I collagen cytokine mRNAs by isolated from wound chambers implanted into mice. Five days after chamber implantation, CD34+ fibrocytes but not CD14+ monocytes or CD90+ T expressed mRNA for...

10.4049/jimmunol.160.1.419 article EN The Journal of Immunology 1998-01-01

OBJECTIVE—Data from experimental studies have suggested that the increased formation of advanced glycation end products (AGEs) is one causes endothelial dysfunction in diabetes. This study was performed to investigate whether changes endothelium-dependent vasodilation, a marker function, were related serum AGEs concentrations patients with type 2 RESEARCH DESIGN AND METHODS—For this study, 170 diabetes and 83 healthy nondiabetic control subjects similar age recruited. Serum assayed by...

10.2337/diacare.25.6.1055 article EN Diabetes Care 2002-06-01

Objective Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine whose involvement in tumor necrosis α (TNFα) synthesis and T cell activation suggests role the pathogenesis of rheumatoid arthritis (RA). Antagonism MIF associated with marked inhibition animal models RA. Uniquely, inducible by low concentrations glucocorticoids. We sought to investigate expression RA synovial tissue. Methods was demonstrated human synovium immunohistochemistry, flow cytometry, enzyme-linked...

10.1002/1529-0131(199908)42:8<1601::aid-anr6>3.0.co;2-b article EN Arthritis & Rheumatism 1999-08-01

MIF is a proinflammatory cytokine that has been implicated in the pathogenesis of sepsis, arthritis, and other inflammatory diseases. Antibodies against are effective experimental models inflammation, there interest strategies to inhibit its deleterious activities. Here we identify mechanism inhibiting pro-inflammatory activities by targeting tautomerase activity. We designed small molecules this activity; lead molecule, “ISO-1 ((S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid...

10.1074/jbc.c500243200 article EN cc-by Journal of Biological Chemistry 2005-08-23
Coming Soon ...